Cargando…

Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers?

Vaccines are the most important public health measure to protect people from COVID-19 worldwide. In addition, healthcare workers account for a large number of infected people. Protecting this population from COVID-19 seems crucial to preserve healthcare systems. In a context of few doses available,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pean De Ponfilly, G., Pilmis, B., El Kaibi, I., Castreau, N., Laplanche, S., Le Monnier, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259040/ https://www.ncbi.nlm.nih.gov/pubmed/34242841 http://dx.doi.org/10.1016/j.idnow.2021.07.001

Ejemplares similares

Evolution of anti-SARS-CoV-2 immune response in a cohort of French healthcare workers followed for 7 months
por: Pilmis, B., et al.
Publicado: (2022)

Antimicrobial Stewardship Program: Reducing Antibiotic’s Spectrum of Activity Is not the Solution to Limit the Emergence of Multidrug-Resistant Bacteria
por: Saliba, Rindala, et al.
Publicado: (2022)

Empiric Treatment in HAP/VAP: “Don’t You Want to Take a Leap of Faith?”
por: Chaïbi, Khalil, et al.
Publicado: (2022)

Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department
por: NguyenVan, Jean-Claude, et al.
Publicado: (2021)

T‐cell response after first dose of BNT162b2 SARS‐CoV‐2 vaccine among healthcare workers with previous infection or cross‐reactive immunity
por: Casado, Jose L, et al.
Publicado: (2021)

SARS-CoV-2 infection in fully vaccinated healthcare workers
por: Hernández Porto, Miriam, et al.
Publicado: (2022)

Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: example from an Israeli healthcare worker cohort.
por: Abu Jabal, Kamal, et al.
Publicado: (2022)

Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history
por: Ota, Kenji, et al.
Publicado: (2023)

Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

Healthcare workers benefit from second dose of COVID-19 mRNA vaccine: Effects of partial and full vaccination on sick leave duration and symptoms
por: Strum, Earl, et al.
Publicado: (2022)

Depressive symptoms predict antibody titers after a second dose of the SARS-CoV-2 BNT162b2 vaccine among hospital workers in Japan
por: Kaneko, Hiroshi, et al.
Publicado: (2023)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 among healthcare workers
por: Sansone, Emanuele, et al.
Publicado: (2021)

Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy– Update on the 28th of March 2021
por: Mateo-Urdiales, Alberto, et al.
Publicado: (2021)

Natural history of SARS-CoV-2 infection in healthcare workers in Northern Italy
por: Bongiovanni, M., et al.
Publicado: (2020)

Safety of Pfizer-BioNTech vaccine in a cohort of healthcare providers: Differences between naïve and previously infected by SARS-CoV-2
por: Chong-Valbuena, Andrea, et al.
Publicado: (2022)

Clinical and operational impact of rapid point-of-care SARS-CoV-2 detection in an emergency department
por: Gerlier, Camille, et al.
Publicado: (2021)

SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker
por: Gupta, Aayush, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Symptomatic Infections in Previously Infected or Vaccinated South African Healthcare Workers
por: Nunes, Marta C., et al.
Publicado: (2022)

Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection
por: Baos, Elvira, et al.
Publicado: (2022)

Previous SARS‐CoV‐2 infection or a third dose of vaccine elicited cross‐variant neutralising antibodies in vaccinated solid‐organ transplant recipients
por: Chang, Chih‐Chao, et al.
Publicado: (2022)

Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in Sweden
por: Ljung, Rickard, et al.
Publicado: (2022)

The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose—Study in Healthcare Workers Group in Poland
por: Kwiecińska-Piróg, Joanna, et al.
Publicado: (2021)

Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine
por: Yamamoto, Shohei, et al.
Publicado: (2022)

Persistence of Anti-S1 IgG against SARS-CoV-2 Eight Months after the Booster Dose of Vaccine in Naive and Previously Infected Healthcare Workers
por: Algarate, Sonia, et al.
Publicado: (2023)

Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects
por: Ferrari, Davide, et al.
Publicado: (2021)

Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods
por: de Ponfilly, Gauthier Péan, et al.
Publicado: (2021)

Long-term immunogenicity in previously vaccinated healthcare workers with inactivated virus vaccine after SARS-CoV-2 infection or booster vaccination
por: Terbsiri, Varalee, et al.
Publicado: (2023)

Broad-based SARS-CoV-2 testing program for healthcare workers in a primary care hospital in France
por: Chas, Julie, et al.
Publicado: (2021)

The pandemic toll and post-acute sequelae of SARS-CoV-2 in healthcare workers at a Swiss University Hospital
por: Nehme, Mayssam, et al.
Publicado: (2022)

Spike Antibody Titers Evaluation after a 2-Dose Regimen of BNT162b2 Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2
por: Kayukawa, Satoshi, et al.
Publicado: (2021)

Vaccine against SARS-CoV-2 in previously infected health care workers
por: Parisi, Saverio Giuseppe
Publicado: (2021)

From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach
por: El Zowalaty, Mohamed E., et al.
Publicado: (2020)

Antibody Response after BNT162b2 Vaccination in Healthcare Workers Previously Exposed and Not Exposed to SARS-CoV-2
por: Salvaggio, Marcello, et al.
Publicado: (2021)

Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France
por: Tamandjou, Cynthia, et al.
Publicado: (2023)

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
por: Havervall, Sebastian, et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves
por: de Visscher, Nathalie, et al.
Publicado: (2022)

Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination
por: Kim, Namhee, et al.
Publicado: (2021)

Prevention and protection measures of healthcare workers exposed to SARS-CoV-2 in a university hospital in Bari, Apulia, Southern Italy
por: Vimercati, L., et al.
Publicado: (2020)

Persistent SARS-COV-2 infection in vaccinated individual with three doses of COVID-19 vaccine
por: Silva Vasconcelos, Germana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dve02o7qhe04ljqsd76qfdi6ld